Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.27 trillion and total revenue of $109.81 billion.
Market Cap
1.27T
Revenue
109.81B
Profits
-41.34B
PE Ratio
n/a
Profit Margin
-37.64%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 123.19B | -2.24% | 1,430,336 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 67.61B | -0.51% | 565,814 | 14.92B |
| 3 | ARGX | argenx SE | 54.63B | -3.50% | 325,036 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.89B | -4.49% | 2,538,113 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 39.73B | -2.22% | 1,355,157 | - |
| 6 | ONC | BeOne Medicines AG | 33.21B | -1.36% | 254,492 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 32.49B | -2.64% | 2,518,708 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 27.09B | -10.83% | 9,176,778 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.87B | -2.28% | 6,237,586 | 8.26M |
| 10 | INSM | Insmed Incorporated | 25.06B | -2.24% | 2,931,184 | 819.56M |
| 11 | INCY | Incyte Corporation | 23.32B | -1.53% | 1,643,980 | 5.36B |
| 12 | BNTX | BioNTech SE | 23.14B | -1.60% | 551,666 | 3.23B |
| 13 | GMAB | Genmab A/S | 17.55B | -2.62% | 4,927,153 | 3.90B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 16.84B | -4.75% | 6,374,991 | 579.96M |
| 15 | ASND | Ascendis Pharma A/S | 16.80B | -1.81% | 375,365 | 998.25M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.32B | -1.25% | 636,248 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.20B | -1.05% | 3,219,800 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.37B | -4.16% | 294,013 | 1.13B |
| 19 | ABVX | ABIVAX Société Anonyme | 12.11B | -0.60% | 837,549 | 5.67M |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.03B | -6.09% | 804,605 | 708.24M |
| 21 | SMMT | Summit Therapeutics Inc. | 11.84B | -1.49% | 2,724,961 | - |
| 22 | CYTK | Cytokinetics, Incorporated | 11.52B | -1.39% | 1,759,780 | 105.82M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 11.43B | -1.42% | 1,556,905 | 3.24B |
| 24 | TECH | Bio-Techne Corporation | 11.11B | 0.21% | 2,938,081 | 1.21B |
| 25 | KRYS | Krystal Biotech, Inc. | 10.78B | -1.46% | 363,514 | 417.30M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.76B | -9.05% | 2,952,941 | 622.01M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.02B | 0.06% | 787,801 | - |
| 28 | CORT | Corcept Therapeutics Incorporated | 9.86B | -1.47% | 1,128,598 | 769.10M |
| 29 | NUVL | Nuvalent, Inc. | 9.83B | 0.06% | 2,057,856 | - |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.82B | 0.29% | 665,909 | 51.48M |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 9.63B | -9.37% | 11,607,907 | 1.06B |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 9.06B | -2.44% | 398,571 | 7.46M |
| 33 | HALO | Halozyme Therapeutics, Inc. | 9.04B | -3.08% | 1,465,870 | 1.51B |
| 34 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.81B | -0.05% | 7,355,510 | 18.07M |
| 35 | IBRX | ImmunityBio, Inc. | 8.61B | -7.33% | 12,861,908 | 140.98M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 8.59B | -1.02% | 778,881 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 8.45B | -4.52% | 954,566 | 74.06M |
| 38 | PCVX | Vaxcyte, Inc. | 8.41B | -2.71% | 623,949 | - |
| 39 | IMVT | Immunovant, Inc. | 8.15B | -3.36% | 1,095,102 | - |
| 40 | TGTX | TG Therapeutics, Inc. | 8.10B | -3.28% | 1,230,096 | 700.35M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 7.45B | -4.36% | 539,112 | 569.61M |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.43B | -6.13% | 505,896 | 217.17M |
| 43 | PTCT | PTC Therapeutics, Inc. | 7.04B | -5.25% | 1,049,034 | 827.11M |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.80B | -2.12% | 829,110 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.66B | -2.87% | 1,535,682 | 7.50M |
| 46 | COGT | Cogent Biosciences, Inc. | 6.64B | -4.05% | 2,051,929 | - |
| 47 | CGON | CG Oncology, Inc. | 6.64B | 2.62% | 1,042,659 | 5.07M |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 6.27B | -1.97% | 148,567 | 274.48M |
| 49 | DFTX | Definium Therapeutics, Inc. | 6.25B | -2.85% | 2,554,628 | - |
| 50 | BLTE | Belite Bio, Inc | 5.87B | -2.55% | 153,709 | - |
| 51 | ERAS | Erasca, Inc. | 5.76B | -3.39% | 3,018,548 | - |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 5.34B | -2.43% | 842,583 | 1.34M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.26B | -3.22% | 1,247,315 | 536.20M |
| 54 | CELC | Celcuity Inc. | 5.25B | -5.22% | 698,625 | - |
| 55 | LEGN | Legend Biotech Corporation | 5.24B | -1.10% | 1,343,006 | 1.14B |
| 56 | ORKA | Oruka Therapeutics, Inc. | 5.23B | -1.68% | 502,966 | - |
| 57 | CRSP | CRISPR Therapeutics AG | 5.15B | -5.31% | 2,074,868 | 4.10M |
| 58 | MANE | Veradermics, Incorporated | 5.00B | -4.25% | 350,821 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.89B | -6.08% | 1,067,990 | - |
| 60 | CAI | Caris Life Sciences, Inc. | 4.80B | -4.92% | 2,257,882 | 907.29M |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.51B | -5.54% | 2,158,702 | - |
| 62 | TNGX | Tango Therapeutics, Inc. | 4.49B | 1.77% | 3,372,650 | 56.99M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 4.49B | -0.72% | 1,380,932 | 1.10B |
| 64 | RLAY | Relay Therapeutics, Inc. | 4.36B | -3.59% | 3,188,036 | 10.68M |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 4.12B | -1.84% | 564,164 | 22.57M |
| 66 | DNLI | Denali Therapeutics Inc. | 4.08B | -5.62% | 1,397,862 | - |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.89B | 0.69% | 690,363 | - |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.87B | -3.50% | 1,514,764 | - |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | - | 1,346,495 | 596.96M |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.84B | -5.43% | 186,392 | 803.79M |
| 71 | GPCR | Structure Therapeutics Inc. | 3.79B | -3.23% | 736,850 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.64B | -3.47% | 811,732 | 236.00M |
| 73 | ALMS | Alumis Inc. | 3.61B | -6.57% | 930,690 | 8.40M |
| 74 | ELVN | Enliven Therapeutics, Inc. | 3.57B | -2.09% | 623,676 | - |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.52B | -0.78% | 677,503 | 225.27M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.47B | -3.61% | 1,571,937 | 415.62M |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 3.32B | -2.28% | 1,578,085 | 670.00M |
| 78 | BEAM | Beam Therapeutics Inc. | 3.25B | -8.77% | 2,833,762 | 164.01M |
| 79 | CLDX | Celldex Therapeutics, Inc. | 3.07B | 0.33% | 693,940 | 865.00K |
| 80 | VERA | Vera Therapeutics, Inc. | 3.01B | -1.06% | 3,403,420 | - |
| 81 | QURE | uniQure N.V. | 2.93B | -4.16% | 1,140,261 | 18.09M |
| 82 | IRON | Disc Medicine, Inc. | 2.93B | -2.98% | 324,984 | - |
| 83 | MBX | MBX Biosciences, Inc. | 2.91B | -7.09% | 851,868 | - |
| 84 | KLRA | Kailera Therapeutics, Inc. | 2.68B | -1.57% | 558,281 | - |
| 85 | IMNM | Immunome, Inc. | 2.64B | -3.39% | 1,105,133 | 4.02M |
| 86 | KOD | Kodiak Sciences Inc. | 2.58B | 3.07% | 996,539 | - |
| 87 | TRVI | Trevi Therapeutics, Inc. | 2.53B | -3.04% | 1,027,147 | - |
| 88 | SLS | SELLAS Life Sciences Group, Inc. | 2.51B | -5.55% | 6,405,799 | - |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.50B | -2.00% | 727,682 | - |
| 90 | TARS | Tarsus Pharmaceuticals, Inc. | 2.50B | -9.35% | 2,367,148 | 535.08M |
| 91 | AGIO | Agios Pharmaceuticals, Inc. | 2.45B | -3.65% | 1,114,794 | 66.05M |
| 92 | PHVS | Pharvaris N.V. | 2.45B | -2.47% | 639,255 | - |
| 93 | VCEL | Vericel Corporation | 2.40B | -2.71% | 451,850 | 292.09M |
| 94 | NRIX | Nurix Therapeutics, Inc. | 2.39B | -6.60% | 1,554,089 | 36.77M |
| 95 | NKTR | Nektar Therapeutics | 2.38B | -3.51% | 786,177 | 55.63M |
| 96 | BHVN | Biohaven Ltd. | 2.34B | -7.39% | 2,130,124 | - |
| 97 | ZLAB | Zai Lab Limited | 2.30B | 2.55% | 1,189,829 | 453.28M |
| 98 | OCUL | Ocular Therapeutix, Inc. | 2.23B | -3.23% | 1,875,626 | 52.04M |
| 99 | KARD | Kardigan, Inc. | 2.20B | 0.76% | 338,717 | - |
| 100 | VRDN | Viridian Therapeutics, Inc. | 2.18B | -2.28% | 1,431,508 | 70.92M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.13B | -3.59% | 668,808 | 899.11M |
| 102 | ADMA | ADMA Biologics, Inc. | 2.10B | -2.05% | 2,343,235 | 509.86M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 2.09B | -4.95% | 2,100,756 | 217.17M |
| 104 | ABCL | AbCellera Biologics Inc. | 2.08B | -6.72% | 7,281,658 | 79.21M |
| 105 | PVLA | Palvella Therapeutics, Inc. | 2.08B | -4.16% | 214,942 | - |
| 106 | NBTX | Nanobiotix S.A. | 2.06B | 2.88% | 119,851 | 38.27M |
| 107 | SION | Sionna Therapeutics, Inc. | 2.04B | 0.78% | 370,997 | - |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -4.88% | 1,202,221 | 298.30M |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 2.03B | -3.50% | 2,850,250 | 7.47M |
| 110 | NUVB | Nuvation Bio Inc. | 2.02B | -4.91% | 6,087,984 | 143.05M |
| 111 | MESO | Mesoblast Limited | 2.02B | 4.11% | 292,515 | 65.38M |
| 112 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | -7.65% | 3,029,966 | 2.18B |
| 113 | RAPP | Rapport Therapeutics, Inc. | 2.00B | -0.71% | 435,479 | 20.00M |
| 114 | NTLA | Intellia Therapeutics, Inc. | 1.99B | -7.93% | 6,175,405 | 66.09M |
| 115 | LKFT | Lakefront Biotherapeutics NV | 1.98B | -1.05% | 136,739 | 1.20B |
| 116 | ANAB | AnaptysBio, Inc. | 1.97B | -0.30% | 400,960 | 232.39M |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.95B | -4.42% | 614,856 | 32.08M |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.95B | -0.79% | 1,002,225 | - |
| 119 | GLUE | Monte Rosa Therapeutics, Inc. | 1.95B | -6.04% | 1,718,268 | 42.95M |
| 120 | ATAI | AtaiBeckley Inc. | 1.90B | -3.00% | 8,001,836 | 3.49M |
| 121 | BCAX | Bicara Therapeutics Inc. | 1.90B | -2.59% | 584,430 | - |
| 122 | PGEN | Precigen, Inc. | 1.90B | -3.80% | 3,455,391 | 31.60M |
| 123 | RXRX | Recursion Pharmaceuticals, Inc. | 1.89B | -5.32% | 20,808,232 | 66.41M |
| 124 | IOVA | Iovance Biotherapeutics, Inc. | 1.89B | -3.20% | 9,924,816 | 285.61M |
| 125 | URGN | UroGen Pharma Ltd. | 1.88B | -4.15% | 1,281,162 | 140.49M |
| 126 | ZYME | Zymeworks Inc. | 1.85B | -4.40% | 483,248 | 81.26M |
| 127 | GENB | Generate Biomedicines, Inc. | 1.84B | -8.87% | 886,246 | 30.30M |
| 128 | GHRS | GH Research PLC | 1.82B | -2.54% | 128,431 | - |
| 129 | ZBIO | Zenas BioPharma, Inc. | 1.81B | -2.34% | 959,988 | 10.00M |
| 130 | ABSI | Absci Corporation | 1.80B | -7.59% | 4,696,499 | 1.84M |
| 131 | MPLT | MapLight Therapeutics, Inc. | 1.78B | -1.21% | 1,183,970 | - |
| 132 | COAG | Hemab Therapeutics Holdings, Inc. | 1.78B | 2.23% | 210,393 | - |
| 133 | DMRA | Damora Therapeutics, Inc. | 1.76B | -7.31% | 312,623 | - |
| 134 | AAPG | Ascentage Pharma Group International | 1.71B | 5.66% | 3,626 | 82.08M |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.69B | -5.71% | 789,762 | 20.00M |
| 136 | MLTX | MoonLake Immunotherapeutics | 1.68B | 2.16% | 1,939,621 | - |
| 137 | FTRE | Fortrea Holdings Inc. | 1.68B | 0.51% | 832,038 | 2.71B |
| 138 | VIR | Vir Biotechnology, Inc. | 1.68B | -3.68% | 1,676,892 | 65.50M |
| 139 | INVA | Innoviva, Inc. | 1.64B | 0.18% | 2,676,231 | 420.69M |
| 140 | IMCR | Immunocore Holdings plc | 1.63B | -3.42% | 410,617 | 412.81M |
| 141 | SEPN | Septerna, Inc. | 1.62B | -5.05% | 378,159 | 72.26M |
| 142 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.57B | 2.01% | 4,388,990 | 204.73M |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.57B | 0.06% | 436,615 | - |
| 144 | AKTS | Aktis Oncology, Inc. | 1.54B | -1.90% | 487,196 | 8.28M |
| 145 | NVAX | Novavax, Inc. | 1.53B | -0.74% | 5,096,180 | 596.34M |
| 146 | SVRA | Savara Inc. | 1.53B | -4.13% | 1,720,221 | - |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.36B | -10.44% | 369,466 | 1.30M |
| 148 | IMTX | Immatics N.V. | 1.32B | -2.81% | 264,070 | 43.00M |
| 149 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | -3.27% | 1,207,798 | - |
| 150 | ARDX | Ardelyx, Inc. | 1.30B | -1.86% | 2,336,676 | 427.68M |
| 151 | TRAX | First Tracks Biotherapeutics, Inc. | 1.26B | 11.85% | 1,919,413 | - |
| 152 | MNKD | MannKind Corporation | 1.26B | -1.21% | 4,247,280 | 360.78M |
| 153 | CAPR | Capricor Therapeutics, Inc. | 1.25B | -4.40% | 1,226,721 | 11.13M |
| 154 | AVLN | Avalyn Pharma Inc. | 1.24B | -2.97% | 321,866 | - |
| 155 | JBIO | Jade Biosciences, Inc. | 1.24B | -6.81% | 1,413,153 | - |
| 156 | MGTX | MeiraGTx Holdings plc | 1.24B | -3.95% | 735,732 | 79.76M |
| 157 | EYPT | EyePoint, Inc. | 1.23B | -0.81% | 1,638,975 | 7.61M |
| 158 | WVE | Wave Life Sciences Ltd. | 1.20B | -0.95% | 3,550,065 | 71.80M |
| 159 | XNCR | Xencor, Inc. | 1.18B | -1.67% | 544,648 | 97.36M |
| 160 | SPTX | Seaport Therapeutics, Inc. | 1.16B | 5.22% | 76,158 | - |
| 161 | SANA | Sana Biotechnology, Inc. | 1.15B | -2.04% | 2,904,836 | - |
| 162 | DRTS | Alpha Tau Medical Ltd. | 1.15B | -2.08% | 640,360 | - |
| 163 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | -0.82% | 1,074,045 | - |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 1.11B | -1.36% | 684,711 | - |
| 165 | FBRX | Forte Biosciences, Inc. | 1.07B | 19.67% | 3,186,095 | - |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | -3.01% | 983,796 | - |
| 167 | VOR | Vor Biopharma Inc. | 1.04B | -3.09% | 2,184,946 | - |
| 168 | SLDB | Solid Biosciences Inc. | 1.03B | -6.46% | 1,472,640 | - |
| 169 | KURA | Kura Oncology, Inc. | 1.02B | -5.22% | 1,338,763 | 71.64M |
| 170 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -3.71% | 852,798 | 59.00K |
| 171 | IVA | Inventiva S.A. | 1.01B | -5.08% | 582,528 | 7.94M |
| 172 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | 3.70% | 2,325,327 | 204.89M |
| 173 | JANX | Janux Therapeutics, Inc. | 1.00B | -2.09% | 888,415 | 13.73M |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 986.12M | -1.33% | 2,298,828 | 69.64M |
| 175 | PHAR | Pharming Group N.V. | 970.52M | -1.28% | 13,764 | 369.49M |
| 176 | DBVT | DBV Technologies S.A. | 964.84M | 2.55% | 151,098 | 5.74M |
| 177 | GERN | Geron Corporation | 962.28M | -3.85% | 10,348,868 | 196.12M |
| 178 | ANNX | Annexon, Inc. | 950.29M | -2.36% | 2,736,831 | - |
| 179 | DSGN | Design Therapeutics, Inc. | 948.72M | -1.49% | 836,764 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 948.18M | -6.61% | 2,950,552 | 191.45M |
| 181 | LBRX | LB Pharmaceuticals Inc | 944.90M | -2.34% | 186,440 | - |
| 182 | FTH | Faeth Therapeutics, Inc. | 932.16M | 11.12% | 238,098 | - |
| 183 | ANRO | Alto Neuroscience, Inc. | 929.29M | -4.20% | 517,065 | - |
| 184 | REPL | Replimune Group, Inc. | 922.56M | -1.08% | 2,304,568 | - |
| 185 | TENX | Tenax Therapeutics, Inc. | 896.66M | -4.20% | 1,048,512 | - |
| 186 | TBPH | Theravance Biopharma, Inc. | 877.45M | -0.29% | 868,515 | 109.78M |
| 187 | OCS | Oculis Holding AG | 823.09M | -0.51% | 201,537 | 1.40M |
| 188 | CTMX | CytomX Therapeutics, Inc. | 818.56M | -4.93% | 2,992,096 | 35.54M |
| 189 | CLYM | Climb Bio, Inc. | 801.65M | 1.30% | 1,254,119 | - |
| 190 | ODTX | Odyssey Therapeutics, Inc. | 799.08M | -0.83% | 619,527 | 1.06M |
| 191 | IMMX | Immix Biopharma, Inc. | 790.92M | 0.18% | 1,624,145 | - |
| 192 | NGNE | Neurogene Inc. | 789.70M | -7.49% | 290,565 | 925.00K |
| 193 | ZVRA | Zevra Therapeutics, Inc. | 789.19M | -4.23% | 2,060,243 | 122.29M |
| 194 | SPRY | ARS Pharmaceuticals, Inc. | 788.47M | 0.76% | 1,397,482 | 98.99M |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 787.26M | -2.77% | 462,500 | 299.77M |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 779.32M | -2.28% | 1,401,876 | 8.37M |
| 197 | SLBT | SL Science Holding Limited | 764.49M | 3.73% | 111,240 | - |
| 198 | DRUG | Bright Minds Biosciences Inc. | 754.68M | -0.46% | 331,431 | - |
| 199 | AURA | Aura Biosciences, Inc. | 754.45M | -2.29% | 442,809 | - |
| 200 | SGP | SpyGlass Pharma, Inc. | 752.92M | 12.21% | 169,472 | - |
| 201 | OMER | Omeros Corporation | 744.02M | 0.10% | 1,090,256 | 9.89M |
| 202 | GYRE | Gyre Therapeutics, Inc. | 726.91M | -4.96% | 67,004 | 117.05M |
| 203 | RGNX | REGENXBIO Inc. | 721.20M | -10.86% | 3,350,906 | 87.82M |
| 204 | MNPR | Monopar Therapeutics Inc. | 714.09M | 2.01% | 149,261 | - |
| 205 | CADL | Candel Therapeutics, Inc. | 695.33M | -4.04% | 1,190,953 | - |
| 206 | ALLO | Allogene Therapeutics, Inc. | 690.31M | -4.76% | 7,779,872 | 22.00K |
| 207 | PRME | Prime Medicine, Inc. | 682.73M | -10.64% | 6,656,560 | 4.03M |
| 208 | RLMD | Relmada Therapeutics, Inc. | 672.35M | -1.54% | 1,444,730 | - |
| 209 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 666.49M | -8.47% | 389,512 | - |
| 210 | CRMD | CorMedix Inc. | 659.00M | -3.11% | 808,248 | 400.05M |
| 211 | TECX | Tectonic Therapeutic, Inc. | 648.53M | -2.55% | 100,567 | - |
| 212 | AGMB | AgomAb Therapeutics NV | 644.16M | 0.38% | 47,228 | - |
| 213 | FDMT | 4D Molecular Therapeutics, Inc. | 643.52M | -4.50% | 683,555 | 88.24M |
| 214 | ACHV | Achieve Life Sciences, Inc. | 627.25M | -4.53% | 2,050,608 | - |
| 215 | MDXG | MiMedx Group, Inc. | 612.17M | -0.72% | 670,183 | 389.42M |
| 216 | DNA | Ginkgo Bioworks Holdings, Inc. | 593.80M | -6.58% | 1,085,057 | 151.40M |
| 217 | ALT | Altimmune, Inc. | 593.15M | -2.24% | 2,992,814 | 36.00K |
| 218 | NVCT | Nuvectis Pharma, Inc. | 578.49M | -3.37% | 224,442 | - |
| 219 | CBIO | Crescent Biopharma, Inc. | 576.19M | 3.46% | 302,029 | 11.88M |
| 220 | EIKN | Eikon Therapeutics, Inc. | 572.79M | -5.70% | 281,982 | - |
| 221 | CTNM | Contineum Therapeutics, Inc. | 567.90M | -1.68% | 279,310 | - |
| 222 | XOMA | XOMA Royalty Corporation | 554.56M | -1.29% | 295,648 | 48.56M |
| 223 | ASMB | Assembly Biosciences, Inc. | 542.99M | -1.69% | 169,991 | 71.10M |
| 224 | ARVN | Arvinas, Inc. | 533.59M | -3.16% | 423,161 | 89.40M |
| 225 | PROK | ProKidney Corp. | 531.62M | -2.22% | 936,859 | 889.00K |
| 226 | KYTX | Kyverna Therapeutics, Inc. | 515.85M | -13.51% | 1,991,109 | - |
| 227 | STTK | Shattuck Labs, Inc. | 509.16M | -5.55% | 1,727,054 | 1.00M |
| 228 | EDIT | Editas Medicine, Inc. | 500.29M | -1.21% | 3,592,112 | 38.69M |
| 229 | OCGN | Ocugen, Inc. | 497.63M | - | 3,513,211 | 4.47M |
| 230 | RZLT | Rezolute, Inc. | 496.22M | -7.41% | 2,211,192 | - |
| 231 | STRO | Sutro Biopharma, Inc. | 492.64M | -0.87% | 242,434 | 99.61M |
| 232 | VSTM | Verastem, Inc. | 485.94M | 2.41% | 2,989,325 | 49.59M |
| 233 | ZURA | Zura Bio Limited | 485.44M | -7.26% | 1,254,557 | - |
| 234 | CABA | Cabaletta Bio, Inc. | 485.09M | -4.49% | 6,377,893 | - |
| 235 | PRTA | Prothena Corporation plc | 483.74M | -4.15% | 505,129 | 57.94M |
| 236 | PRLD | Prelude Therapeutics Incorporated | 476.55M | -2.14% | 577,888 | 16.72M |
| 237 | EVMN | Evommune, Inc. | 475.80M | -2.22% | 585,867 | 10.00M |
| 238 | VALN | Valneva SE | 472.44M | -4.72% | 16,116 | 180.25M |
| 239 | OVID | Ovid Therapeutics Inc. | 470.33M | -3.08% | 1,394,125 | 7.12M |
| 240 | ARTV | Artiva Biotherapeutics, Inc. | 468.39M | 2.44% | 442,216 | 251.00K |
| 241 | BNTC | Benitec Biopharma Inc. | 461.04M | -0.45% | 84,568 | - |
| 242 | SGMT | Sagimet Biosciences Inc. | 455.11M | 0.27% | 1,113,089 | - |
| 243 | CCCC | C4 Therapeutics, Inc. | 448.90M | -5.36% | 2,583,449 | 34.86M |
| 244 | LRMR | Larimar Therapeutics, Inc. | 446.76M | 3.63% | 3,445,587 | - |
| 245 | EPRX | Eupraxia Pharmaceuticals Inc. | 437.08M | -3.33% | 245,316 | - |
| 246 | SLN | Silence Therapeutics plc | 429.36M | -7.81% | 365,407 | 839.00K |
| 247 | AUTL | Autolus Therapeutics plc | 428.49M | -4.73% | 1,348,300 | 92.62M |
| 248 | RCKT | Rocket Pharmaceuticals, Inc. | 426.95M | -6.68% | 1,946,267 | - |
| 249 | HELP | Cybin Inc. | 425.83M | 3.62% | 1,525,452 | - |
| 250 | CMPX | Compass Therapeutics, Inc. | 419.60M | 0.87% | 2,797,054 | 850.00K |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 415.95M | 11.36% | 918,438 | 9.01M |
| 252 | VTVT | vTv Therapeutics Inc. | 415.59M | 0.15% | 54,504 | 36.84M |
| 253 | DMAC | DiaMedica Therapeutics Inc. | 413.29M | -0.52% | 163,891 | - |
| 254 | UPB | Upstream Bio, Inc. | 409.78M | -3.59% | 341,646 | 3.32M |
| 255 | PBYI | Puma Biotechnology, Inc. | 407.20M | 1.27% | 342,226 | 227.18M |
| 256 | IPSC | Century Therapeutics, Inc. | 405.80M | -2.60% | 1,207,814 | 109.16M |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 399.34M | 1.63% | 306,538 | - |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 398.37M | -3.86% | 179,224 | 69.21M |
| 259 | ABEO | Abeona Therapeutics Inc. | 397.83M | -1.97% | 1,632,094 | 14.54M |
| 260 | ANL | Adlai Nortye Ltd. | 394.80M | -7.58% | 118,560 | 5.00M |
| 261 | LXEO | Lexeo Therapeutics, Inc. | 378.47M | -4.55% | 744,574 | - |
| 262 | VNDA | Vanda Pharmaceuticals Inc. | 375.25M | -2.19% | 596,708 | 217.78M |
| 263 | VCRE | Vicore Pharma Holding AB (publ) | 372.65M | -1.01% | 23,270 | 370.61K |
| 264 | FENC | Fennec Pharmaceuticals Inc. | 364.39M | 1.75% | 173,137 | 51.00M |
| 265 | FATE | Fate Therapeutics, Inc. | 361.33M | -0.32% | 6,523,745 | 6.32M |
| 266 | LYEL | Lyell Immunopharma, Inc. | 350.24M | -1.31% | 116,569 | 31.00K |
| 267 | FHTX | Foghorn Therapeutics Inc. | 349.35M | -1.00% | 293,936 | 28.22M |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 347.66M | - | 584,745 | 1.00 |
| 269 | ZNTL | Zentalis Pharmaceuticals, Inc. | 347.39M | 3.83% | 1,403,845 | 26.87M |
| 270 | PALI | Palisade Bio, Inc. | 340.22M | -0.51% | 3,553,737 | - |
| 271 | OABI | OmniAb, Inc. | 331.99M | 2.23% | 863,694 | 28.94M |
| 272 | IMRX | Immuneering Corporation | 330.60M | -4.66% | 827,678 | - |
| 273 | IRD | Opus Genetics, Inc. | 323.66M | -2.49% | 598,438 | 11.98M |
| 274 | LCTX | Lineage Cell Therapeutics, Inc. | 319.10M | -0.78% | 738,914 | 14.78M |
| 275 | NMRA | Neumora Therapeutics, Inc. | 311.28M | 1.82% | 1,024,349 | - |
| 276 | BCYC | Bicycle Therapeutics plc | 307.87M | 5.50% | 804,033 | 63.50M |
| 277 | IFRX | InflaRx N.V. | 301.95M | -0.49% | 986,492 | 33.82K |
| 278 | INDP | Indaptus Therapeutics, Inc. | 297.83M | 5.20% | 59,622 | - |
| 279 | ELDN | Eledon Pharmaceuticals, Inc. | 297.61M | -6.78% | 1,391,149 | - |
| 280 | SABS | SAB Biotherapeutics, Inc. | 292.09M | -3.54% | 296,378 | 114.70K |
| 281 | GLSI | Greenwich LifeSciences, Inc. | 290.63M | 1.18% | 64,615 | - |
| 282 | ALXO | ALX Oncology Holdings Inc. | 285.95M | 3.16% | 781,671 | - |
| 283 | TTRX | Turn Therapeutics Inc. | 281.20M | 7.15% | 163,693 | - |
| 284 | RNAC | Cartesian Therapeutics, Inc. | 277.95M | -2.17% | 133,006 | 1.78M |
| 285 | MGNX | MacroGenics, Inc. | 275.23M | -5.25% | 744,697 | 157.08M |
| 286 | CNXU | Conexeu Sciences Inc. | 272.93M | 2.93% | 45,729 | - |
| 287 | NAGE | Niagen Bioscience, Inc. | 270.56M | -2.87% | 400,284 | 130.42M |
| 288 | SRZN | Surrozen, Inc. | 269.24M | -1.32% | 148,747 | 7.49M |
| 289 | GALT | Galectin Therapeutics Inc. | 267.38M | -7.09% | 528,753 | - |
| 290 | ADAG | Adagene Inc. | 260.33M | 2.34% | 376,844 | 7.67M |
| 291 | TRDA | Entrada Therapeutics, Inc. | 249.35M | -6.49% | 380,492 | 5.74M |
| 292 | PRQR | ProQR Therapeutics N.V. | 244.14M | -1.70% | 549,892 | 15.73M |
| 293 | TARA | Protara Therapeutics, Inc. | 242.80M | 2.86% | 1,008,277 | - |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 241.74M | -3.16% | 54,096 | 18.47M |
| 295 | NAUT | Nautilus Biotechnology, Inc. | 240.18M | -0.53% | 1,710,348 | - |
| 296 | OBIO | Orchestra BioMed Holdings, Inc. | 238.92M | 1.79% | 161,464 | 32.72M |
| 297 | CHRS | Coherus Oncology, Inc. | 237.54M | -5.52% | 930,771 | 46.88M |
| 298 | ACIU | AC Immune SA | 237.09M | -8.08% | 199,728 | 4.62M |
| 299 | KPTI | Karyopharm Therapeutics Inc. | 234.33M | 1.37% | 320,236 | 151.12M |
| 300 | KROS | Keros Therapeutics, Inc. | 233.54M | -1.91% | 259,080 | 33.18M |
| 301 | FULC | Fulcrum Therapeutics, Inc. | 233.22M | -2.51% | 1,557,850 | 80.00M |
| 302 | AVXL | Anavex Life Sciences Corp. | 231.68M | -7.41% | 749,693 | - |
| 303 | IVVD | Invivyd, Inc. | 230.80M | -2.53% | 2,010,378 | 55.87M |
| 304 | CGEN | Compugen Ltd. | 226.06M | -3.24% | 158,767 | 72.66M |
| 305 | DTIL | Precision BioSciences, Inc. | 226.03M | -4.37% | 579,590 | 45.07M |
| 306 | CAMP | Camp4 Therapeutics Corporation | 224.84M | -0.23% | 355,744 | 3.93M |
| 307 | CDXS | Codexis, Inc. | 220.88M | -5.08% | 550,478 | 78.09M |
| 308 | NERV | Minerva Neurosciences, Inc. | 219.90M | - | 235,006 | - |
| 309 | NBP | NovaBridge Biosciences | 219.73M | 2.15% | 483,148 | - |
| 310 | CLLS | Cellectis S.A. | 214.98M | -5.77% | 6,127 | 75.11M |
| 311 | WHWK | Whitehawk Therapeutics, Inc. | 213.52M | 2.85% | 408,641 | 7.15M |
| 312 | RNA | Atrium Therapeutics, Inc. | 213.14M | -3.49% | 242,619 | 36.68M |
| 313 | NKTX | Nkarta, Inc. | 212.49M | -7.48% | 1,305,351 | - |
| 314 | KRRO | Korro Bio, Inc. | 209.99M | 1.82% | 233,780 | 3.84M |
| 315 | VYGR | Voyager Therapeutics, Inc. | 207.85M | -6.52% | 716,461 | 36.49M |
| 316 | IMUX | Immunic, Inc. | 201.19M | -0.07% | 131,813 | - |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 199.74M | -3.84% | 505,595 | 17.56M |
| 318 | NGEN | NervGen Pharma Corp. | 199.66M | 1.08% | 787,313 | - |
| 319 | ARCT | Arcturus Therapeutics Holdings Inc. | 198.11M | -2.65% | 406,783 | 54.71M |
| 320 | PLX | Protalix BioTherapeutics, Inc. | 196.59M | 2.95% | 678,250 | 76.38M |
| 321 | CRBU | Caribou Biosciences, Inc. | 190.92M | -0.77% | 3,477,068 | 11.20M |
| 322 | QTTB | Q32 Bio Inc. | 190.08M | -10.96% | 3,487,704 | 53.74M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 189.96M | -2.59% | 319,065 | - |
| 324 | OTLK | Outlook Therapeutics, Inc. | 189.76M | -6.55% | 7,349,600 | 333.14K |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 188.88M | 2.40% | 3,850,065 | 225.00K |
| 326 | HUMA | Humacyte, Inc. | 187.05M | -0.94% | 13,055,055 | 2.02M |
| 327 | EQ | Equillium, Inc. | 183.99M | -1.69% | 1,758,844 | 4.39M |
| 328 | MDWD | MediWound Ltd. | 183.66M | -2.86% | 85,477 | 14.48M |
| 329 | CNTN | Canton Strategic Holdings, Inc. | 183.55M | 3.93% | 642,080 | - |
| 330 | ACOG | Alpha Cognition Inc. | 183.12M | -1.29% | 56,597 | 10.83M |
| 331 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 179.35M | 0.21% | 216,243 | - |
| 332 | ALEC | Alector, Inc. | 178.75M | -1.53% | 597,113 | 18.42M |
| 333 | NRXP | NRx Pharmaceuticals, Inc. | 175.60M | 1.95% | 764,368 | 2.29M |
| 334 | LENZ | LENZ Therapeutics, Inc. | 175.27M | -3.45% | 1,202,628 | 20.99M |
| 335 | MIST | Milestone Pharmaceuticals Inc. | 174.14M | -2.29% | 457,188 | 1.78M |
| 336 | OKUR | OnKure Therapeutics, Inc. | 172.89M | -4.04% | 193,803 | - |
| 337 | PYXS | Pyxis Oncology, Inc. | 169.16M | 1.14% | 853,109 | 13.86M |
| 338 | IPHA | Innate Pharma S.A. | 168.84M | 0.14% | 11,787 | 10.57M |
| 339 | AARD | Aardvark Therapeutics, Inc. | 165.80M | 52.00% | 4,090,661 | - |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 165.34M | -3.35% | 226,877 | 2.00M |
| 341 | MENS | Jyong Biotech Ltd. | 164.06M | -3.91% | 46,169 | - |
| 342 | ANTX | AN2 Therapeutics, Inc. | 162.07M | -2.81% | 591,722 | - |
| 343 | PEPG | PepGen Inc. | 161.86M | 1.74% | 2,384,082 | - |
| 344 | TLSA | Tiziana Life Sciences Ltd | 159.05M | -2.38% | 244,824 | - |
| 345 | CNTB | Connect Biopharma Holdings Limited | 158.04M | -5.64% | 726,877 | 233.00K |
| 346 | YDES | YD Bio Limited | 156.81M | 4.21% | 70,229 | 510.36K |
| 347 | ARMP | Armata Pharmaceuticals, Inc. | 156.39M | -11.80% | 244,738 | 5.20M |
| 348 | KZIA | Kazia Therapeutics Limited | 154.95M | 4.47% | 240,557 | 1.27M |
| 349 | CUE | Cue Biopharma, Inc. | 154.49M | 0.74% | 287,812 | 32.73M |
| 350 | CBUS | Cibus, Inc. | 154.19M | 6.32% | 606,919 | 4.29M |
| 351 | HURA | TuHURA Biosciences, Inc. | 152.20M | 2.14% | 510,624 | - |
| 352 | MOLN | Molecular Partners AG | 150.17M | - | 439 | 856.30K |
| 353 | AGEN | Agenus Inc. | 139.50M | 3.40% | 833,365 | 123.87M |
| 354 | UNCY | Unicycive Therapeutics, Inc. | 139.11M | -0.95% | 1,129,340 | - |
| 355 | SPRB | Spruce Biosciences, Inc. | 137.81M | -3.23% | 56,469 | 697.00K |
| 356 | GNLX | Genelux Corporation | 134.56M | 1.68% | 248,621 | 8.00K |
| 357 | PMN | ProMIS Neurosciences, Inc. | 127.79M | -0.14% | 101,603 | - |
| 358 | ENGN | enGene Therapeutics Inc. | 127.28M | -1.04% | 1,095,988 | - |
| 359 | GUTS | Fractyl Health, Inc. | 125.76M | 0.15% | 642,143 | 3.00K |
| 360 | ALDX | Aldeyra Therapeutics, Inc. | 124.86M | -10.00% | 1,227,247 | - |
| 361 | COYA | Coya Therapeutics, Inc. | 123.38M | - | 392,165 | 7.94M |
| 362 | SPRO | Spero Therapeutics, Inc. | 121.59M | -0.94% | 482,147 | 61.19M |
| 363 | SEER | Seer, Inc. | 119.31M | -1.36% | 301,330 | 15.17M |
| 364 | VANI | Vivani Medical, Inc. | 117.28M | -12.82% | 1,037,304 | - |
| 365 | NTHI | NeOnc Technologies Holdings, Inc. | 116.44M | - | 35,034 | 39.99K |
| 366 | PLYX | Polaryx Therapeutics, Inc. | 110.31M | -4.12% | 130,394 | - |
| 367 | ENLV | Enlivex Ltd. | 110.24M | -7.30% | 96,541 | - |
| 368 | FBIO | Fortress Biotech, Inc. | 109.62M | 0.30% | 662,568 | 66.16M |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 109.45M | 1.60% | 1,045,291 | 70.00M |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 107.54M | -4.13% | 14,044 | 37.16M |
| 371 | ONCY | Oncolytics Biotech Inc. | 105.90M | -3.55% | 1,016,767 | - |
| 372 | KLRS | Kalaris Therapeutics, Inc. | 105.64M | -1.11% | 10,275 | - |
| 373 | ANIX | Anixa Biosciences, Inc. | 104.11M | -4.97% | 192,673 | - |
| 374 | PYPD | PolyPid Ltd. | 100.28M | -3.51% | 256,613 | - |
| 375 | ICCC | ImmuCell Corporation | 98.52M | -4.93% | 35,129 | 29.93M |
| 376 | CGTX | Cognition Therapeutics, Inc. | 97.55M | - | 1,537,330 | - |
| 377 | INO | Inovio Pharmaceuticals, Inc. | 97.08M | -0.84% | 1,588,561 | 65.34K |
| 378 | ATHE | Alterity Therapeutics Limited | 96.07M | 0.93% | 5,818 | 4.43M |
| 379 | BMEA | Biomea Fusion, Inc. | 95.44M | 0.76% | 1,410,292 | - |
| 380 | ACET | Adicet Bio, Inc. | 92.72M | -1.23% | 60,798 | - |
| 381 | PTHS | Pelthos Therapeutics Inc. | 92.28M | -2.25% | 29,776 | 27.70M |
| 382 | ALPS | Alps Group Inc | 91.74M | -3.28% | 78,639 | 3.74M |
| 383 | RNTX | Rein Therapeutics Inc. | 91.18M | -1.78% | 148,424 | - |
| 384 | CRDF | Cardiff Oncology, Inc. | 90.93M | 0.76% | 801,889 | 525.00K |
| 385 | LONA | LeonaBio, Inc. | 90.18M | 2.24% | 39,046 | - |
| 386 | OKYO | OKYO Pharma Limited | 88.69M | 0.60% | 78,073 | - |
| 387 | NRXS | NeurAxis, Inc. | 88.42M | -0.97% | 37,686 | 4.28M |
| 388 | ATRA | Atara Biotherapeutics, Inc. | 87.94M | -1.91% | 66,882 | 23.14M |
| 389 | MAIA | MAIA Biotechnology, Inc. | 87.55M | -1.37% | 507,033 | - |
| 390 | RANI | Rani Therapeutics Holdings, Inc. | 85.13M | -1.58% | 798,347 | 3.17M |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 84.59M | -3.15% | 29,890 | - |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 83.89M | -4.39% | 349,414 | - |
| 393 | RLYB | Rallybio Corporation | 83.34M | -0.63% | 27,257 | 858.00K |
| 394 | GOSS | Gossamer Bio, Inc. | 82.96M | -3.03% | 12,927,855 | 55.54M |
| 395 | ENTX | Entera Bio Ltd. | 81.58M | -2.65% | 73,613 | 42.00K |
| 396 | CSBR | Champions Oncology, Inc. | 80.82M | 0.17% | 2,481 | 57.95M |
| 397 | ANVS | Annovis Bio, Inc. | 79.13M | -4.62% | 1,166,655 | - |
| 398 | HRTX | Heron Therapeutics, Inc. | 78.44M | -3.29% | 2,714,660 | 150.71M |
| 399 | GANX | Gain Therapeutics, Inc. | 76.78M | -1.10% | 610,322 | - |
| 400 | IBIO | iBio, Inc. | 75.01M | - | 894,768 | 300.00K |
| 401 | OSTX | OS Therapies Incorporated | 74.82M | -2.33% | 757,866 | - |
| 402 | TCRX | TScan Therapeutics, Inc. | 71.23M | 2.83% | 968,682 | 9.14M |
| 403 | HYFT | MindWalk Holdings Corp. | 71.02M | -2.05% | 140,326 | 20.70M |
| 404 | XBIT | XBiotech Inc. | 69.82M | - | 31,234 | - |
| 405 | PLRX | Pliant Therapeutics, Inc. | 68.82M | -0.88% | 757,151 | - |
| 406 | MNOV | MediciNova, Inc. | 68.42M | 0.72% | 17,584 | 596.64K |
| 407 | IMA | ImageneBio, Inc. | 66.66M | 0.17% | 3,562 | 800.00K |
| 408 | ELTX | Elicio Therapeutics, Inc. | 66.37M | -0.29% | 479,070 | - |
| 409 | CING | Cingulate Inc. | 66.13M | -0.81% | 276,670 | - |
| 410 | PMVP | PMV Pharmaceuticals, Inc. | 66.13M | - | 171,966 | - |
| 411 | EDSA | Edesa Biotech, Inc. | 62.33M | -0.14% | 50,545 | - |
| 412 | CNTX | Context Therapeutics Inc. | 59.99M | 9.82% | 3,932,424 | - |
| 413 | BYSI | BeyondSpring Inc. | 59.21M | -3.36% | 29,669 | 1.88M |
| 414 | MCRB | Seres Therapeutics, Inc. | 59.17M | -9.35% | 154,398 | 1.15M |
| 415 | EXOZ | eXoZymes, Inc. | 59.10M | -1.55% | 7,047 | -700.00 |
| 416 | FLNA | Filana Therapeutics, Inc. | 57.00M | -0.84% | 453,673 | - |
| 417 | VRXA | Veraxa Biotech AG | 55.48M | -11.29% | 504,833 | - |
| 418 | INKT | MiNK Therapeutics, Inc. | 55.05M | -3.58% | 18,340 | - |
| 419 | XLO | Xilio Therapeutics, Inc. | 54.44M | -1.09% | 18,964 | 53.48M |
| 420 | BOLD | Boundless Bio, Inc. | 54.13M | -3.98% | 402,885 | - |
| 421 | MREO | Mereo BioPharma Group plc | 53.47M | 3.33% | 1,362,054 | 500.00K |
| 422 | ATYR | aTyr Pharma, Inc. | 53.38M | -6.41% | 1,404,899 | 190.00K |
| 423 | IMMP | Immutep Limited | 52.28M | -0.36% | 191,986 | 5.28M |
| 424 | TIL | Instil Bio, Inc. | 52.22M | 0.52% | 10,093 | - |
| 425 | INMB | INmune Bio Inc. | 51.58M | 8.38% | 1,594,799 | 50.00K |
| 426 | CRVO | CervoMed Inc. | 48.29M | -4.55% | 251,679 | 2.09M |
| 427 | MGX | Metagenomi Therapeutics, Inc. | 47.81M | 0.79% | 349,045 | 22.33M |
| 428 | DWTX | Dogwood Therapeutics, Inc. | 47.75M | 0.71% | 40,604 | - |
| 429 | ELOX | Eloxx Pharmaceuticals, Inc. | 47.67M | -0.76% | 20,431 | - |
| 430 | IBO | Impact BioMedical Inc. | 47.66M | -2.32% | 26,817 | 39.00K |
| 431 | RADX | Radiopharm Theranostics Limited | 46.84M | 2.10% | 12,473 | 10.86M |
| 432 | HYPD | Hyperion DeFi, Inc. | 46.84M | -0.96% | 167,956 | 1.04M |
| 433 | LTRN | Lantern Pharma Inc. | 45.93M | 7.46% | 175,427 | - |
| 434 | VERU | Veru Inc. | 44.62M | -1.07% | 165,199 | 16.89M |
| 435 | PDSB | PDS Biotechnology Corporation | 43.20M | -1.69% | 305,582 | - |
| 436 | RNXT | RenovoRx, Inc. | 41.95M | -1.03% | 40,077 | 1.49M |
| 437 | APLM | Apollomics, Inc. | 41.62M | 0.80% | 3,930 | 8.84M |
| 438 | ALGS | Aligos Therapeutics, Inc. | 40.97M | -2.22% | 109,330 | 4.71M |
| 439 | ESLA | Estrella Immunopharma, Inc. | 39.89M | -2.47% | 49,427 | - |
| 440 | GRCE | Grace Therapeutics, Inc. | 39.87M | 0.41% | 123,132 | - |
| 441 | DYAI | Dyadic International, Inc. | 38.63M | -0.93% | 95,706 | 3.81M |
| 442 | ABVC | ABVC BioPharma, Inc. | 38.16M | 4.14% | 179,304 | 797.92K |
| 443 | NTRB | Nutriband Inc. | 35.98M | -4.21% | 3,324 | 1.80M |
| 444 | GNTA | Genenta Science S.p.A. | 35.39M | -5.66% | 41,510 | - |
| 445 | NNVC | NanoViricides, Inc. | 34.40M | -6.21% | 249,259 | - |
| 446 | LITS | Lite Strategy, Inc. | 34.37M | 1.71% | 103,882 | - |
| 447 | BCTX | BriaCell Therapeutics Corp. | 34.33M | 8.24% | 313,506 | - |
| 448 | SER | Serina Therapeutics, Inc. | 32.09M | -2.73% | 43,698 | 130.00K |
| 449 | SNTI | Senti Biosciences Holdings, Inc. | 32.08M | 3.00% | 96,874 | 38.00K |
| 450 | KYNB | Kyntra Bio, Inc. | 30.79M | 3.89% | 23,495 | 7.44M |
| 451 | TVRD | Tvardi Therapeutics, Inc. | 30.77M | -13.68% | 2,765,243 | - |
| 452 | DARE | Daré Bioscience, Inc. | 30.26M | -2.42% | 49,125 | 1.16M |
| 453 | GRDX | GridAI Technologies Corp. | 29.94M | 8.17% | 84,351 | - |
| 454 | LSTA | Lisata Therapeutics, Inc. | 29.78M | 1.08% | 63,159 | 170.00K |
| 455 | ATNM | Actinium Pharmaceuticals, Inc. | 29.18M | -4.12% | 75,891 | 90.00K |
| 456 | ACTU | Actuate Therapeutics, Inc. | 28.95M | -1.63% | 255,599 | - |
| 457 | PSTV | Plus Therapeutics, Inc. | 27.53M | - | 69,859 | 5.18M |
| 458 | PLRZ | Polyrizon Ltd. | 27.42M | 2.02% | 23,336 | - |
| 459 | IGC | IGC Pharma, Inc. | 27.22M | -2.51% | 462,228 | 1.11M |
| 460 | EVAX | Evaxion A/S | 26.44M | -0.94% | 10,088 | 7.53M |
| 461 | BRNS | Barinthus Biotherapeutics plc | 26.05M | -0.02% | 2,510 | 14.97M |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 25.75M | 1.19% | 56,109 | - |
| 463 | MRKR | Marker Therapeutics, Inc. | 25.18M | -4.43% | 70,900 | 3.55M |
| 464 | AKTX | Akari Therapeutics, Plc | 24.30M | 5.47% | 61,576 | - |
| 465 | SKYE | Skye Bioscience, Inc. | 24.25M | -1.56% | 184,592 | - |
| 466 | CVM | CEL-SCI Corporation | 24.12M | 2.22% | 184,380 | - |
| 467 | NCEL | NewcelX Ltd. | 22.56M | 1.45% | 42,880 | - |
| 468 | CLRB | Cellectar Biosciences, Inc. | 22.54M | 1.81% | 68,390 | - |
| 469 | KALA | KALA BIO, Inc. | 21.84M | -12.96% | 318,657 | - |
| 470 | QNTM | Quantum BioPharma Ltd. | 21.54M | -2.93% | 115,801 | - |
| 471 | CELU | Celularity Inc. | 21.43M | -0.99% | 49,099 | 26.55M |
| 472 | LGVN | Longeveron Inc. | 21.33M | 3.77% | 111,440 | 1.22M |
| 473 | VYNE | VYNE Therapeutics Inc. | 21.27M | -5.12% | 16,093,120 | 454.00K |
| 474 | TVGN | Tevogen Bio Holdings Inc. | 21.19M | -10.28% | 26,607 | - |
| 475 | ATOS | Atossa Therapeutics, Inc. | 20.41M | 0.42% | 65,722 | - |
| 476 | ICU | SeaStar Medical Holding Corporation | 19.90M | 1.02% | 91,744 | 1.44M |
| 477 | LPCN | Lipocine Inc. | 19.87M | -2.43% | 25,271 | 2.00M |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 19.58M | 6.47% | 983,603 | 1.14M |
| 479 | NEUP | Neuphoria Therapeutics Inc. | 19.13M | 0.85% | 9,448 | -13.27K |
| 480 | ALLR | Allarity Therapeutics, Inc. | 18.54M | -2.92% | 103,175 | 345.00K |
| 481 | PLUR | Pluri Inc. | 18.50M | -3.65% | 34,805 | 1.08M |
| 482 | PTN | Palatin Technologies, Inc. | 17.81M | -4.67% | 14,553 | 12.88M |
| 483 | QNCX | Quince Therapeutics, Inc. | 17.15M | 0.29% | 23,627 | - |
| 484 | BIVI | BioVie Inc. | 17.12M | 1.34% | 172,597 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 16.45M | -1.52% | 186,017 | - |
| 486 | CYCN | Cyclerion Therapeutics, Inc. | 16.27M | -2.42% | 27,568 | 1.99M |
| 487 | JSPR | Jasper Therapeutics, Inc. | 16.22M | -0.33% | 1,463,099 | - |
| 488 | LEXX | Lexaria Bioscience Corp. | 16.03M | 5.14% | 55,321 | 368.00K |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 16.00M | 3.81% | 71,831 | 5.61M |
| 490 | HIND | Vyome Holdings, Inc. | 15.79M | 0.90% | 22,422 | 152.72K |
| 491 | GTBP | GT Biopharma, Inc. | 15.33M | -4.96% | 1,043,291 | - |
| 492 | MLEC | Moolec Science SA | 15.25M | - | 2,220 | 7.83M |
| 493 | CALC | CalciMedica, Inc. | 14.69M | -2.09% | 190,128 | - |
| 494 | PASG | Passage Bio, Inc. | 14.66M | -2.97% | 39,595 | - |
| 495 | TPST | Tempest Therapeutics, Inc. | 14.41M | -0.18% | 95,595 | - |
| 496 | COCP | Cocrystal Pharma, Inc. | 13.93M | - | 10,058 | 225.00K |
| 497 | LNAI | Lunai Bioworks Inc. | 13.33M | 7.69% | 85,599 | 20.94K |
| 498 | INAB | IN8bio, Inc. | 13.10M | -5.00% | 113,176 | - |
| 499 | BLRX | BioLineRx Ltd. | 13.08M | 1.98% | 7,393 | 1.40M |
| 500 | INTS | Intensity Therapeutics, Inc. | 12.92M | -2.65% | 29,204 | - |